Cidara Therapeutics

Cidara

The company develops long-acting antiviral drug conjugates to prevent and treat influenza and other serious infectious diseases for high-risk patient populations.

Actym Therapeutics

This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.

Asher Biotherapeutics

This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.

Bicara Therapeutics

This biotechnology company develops dual-action biologics to treat patients with solid tumours by targeting the tumour microenvironment.

Eradivir

This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.

Ankyra Therapeutics

This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.

Radiant Biotherapeutics

This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.

Tizona Therapeutics

This biopharmaceutical company develops first-in-class cancer immunotherapies and antibody-based treatments for patients with advanced solid tumours.